Authors:
LEVEQUE D
GALLIONRENAULT C
MONTEIL H
JEHL F
Citation: D. Leveque et al., ANALYSIS OF RECENT ANTIMICROBIAL AGENTS IN HUMAN BIOLOGICAL-FLUIDS BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography, 815(2), 1998, pp. 163-172
Citation: O. Allix et al., IDENTIFICATION AND FORECAST OF DELAMINATION IN COMPOSITE LAMINATES BYAN INTERLAMINAR INTERFACE MODEL, Composites science and technology, 58(5), 1998, pp. 671-678
Authors:
LEVEQUE D
GALLIONRENAULT C
MONTEIL H
JEHL F
Citation: D. Leveque et al., CAPILLARY ELECTROPHORESIS FOR PHARMACOKINETIC STUDIES, Journal of chromatography B. Biomedical sciences and applications, 697(1-2), 1997, pp. 67-75
Authors:
ELKHAILI H
LEVEQUE D
PETER JD
SALMON Y
SALMON J
POMPEI D
MONTEIL H
JEHL F
Citation: H. Elkhaili et al., PHARMACOKINETICS OF 3 NEW BETA-LACTAMS IN THE YUCATAN MICROPIG MODEL ADMINISTERED BY INTRAVENOUS BOLUS INJECTION AND CONTINUOUS-INFUSION, International journal of antimicrobial agents, 8(2), 1997, pp. 135-141
Authors:
ELKHAILI H
POMPEI D
PETER JD
LINGER L
SALMON J
LEVEQUE D
NIEDERGANG S
SALMON Y
THIERRY RC
MONTEIL H
JEHL F
Citation: H. Elkhaili et al., IN-VIVO PHARMACOKINETIC OF AMIKACIN AND I TS PHARMACODYNAMIC IN COMBINATION WITH CEFEPIME, CEFPIROME AND MEROPENEM IN AN IN-VITRO EX-VIVO MICROPIG MODEL, Pathologie et biologie, 45(5), 1997, pp. 347-356
Authors:
CAVALIER A
LEVEQUE D
PETER JD
SALMON J
ELKHAILI P
SALMON Y
NOBELIS P
GEISERT J
MONTEIL H
JEHL F
Citation: A. Cavalier et al., PHARMACOKINETIC INTERACTION BETWEEN ITRACONAZOLE AND CEFTRIAXONE IN YUCATAN MINIATURE PIGS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 2029-2032
Authors:
ELKHAILI H
KAMILI N
LINGER L
LEVEQUE D
POMPEI D
MONTEIL H
JEHL F
Citation: H. Elkhaili et al., IN-VITRO TIME-KILL CURVES OF CEFEPIME AND CEFPIROME COMBINED WITH AMIKACIN, GENTAMICIN OR CIPROFLOXACIN AGAINST KLEBSIELLA-PNEUMONIAE PRODUCING EXTENDED-SPECTRUM BETA-LACTAMASE, Chemotherapy, 43(4), 1997, pp. 245-253
Authors:
WIHLM J
LIMACHER JM
LEVEQUE D
DUCLOS B
BERGERAT JP
METHLIN G
Citation: J. Wihlm et al., PHARMACOKINETICS OF HIGH-DOSE DOXORUBICIN ADMINISTERED AS A 6-H INTRAVENOUS-INFUSION IN BREAST-CANCER PATIENTS, Bulletin du cancer, 84(6), 1997, pp. 603-608
Authors:
ELKHAILI H
NIEDERGANG S
POMPEI D
LINGER L
LEVEQUE D
JEHL F
Citation: H. Elkhaili et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR MEROPENEM IN SERUM, Journal of chromatography B. Biomedical applications, 686(1), 1996, pp. 19-26
Authors:
ELKHAILI H
LEVEQUE D
PETER JD
SALMON J
SALMON Y
KALTENBACH G
CAVALIER A
LINGER L
POMPEI D
MONTEIL H
JEHL F
Citation: H. Elkhaili et al., MICROPIG AS A RELIABLE MODEL FOR PHARMACO KINETIC INVESTIGATION OF CEFTRIAXONE - CEFEPIME, CEFPIROME AND MEROPENEM, Medecine et maladies infectieuses, 26, 1996, pp. 599-604
Citation: D. Leveque et Mh. Auvray, STUDY OF CARBON-FIBER STRAIN IN MODEL COMPOSITES BY RAMAN-SPECTROSCOPY, Composites science and technology, 56(7), 1996, pp. 749-754
Authors:
KALTENBACH G
LEVEQUE D
PETER JD
SALMON J
ELKHAILI H
CAVALIER A
SALMON Y
MONTEIL H
JEHL F
Citation: G. Kaltenbach et al., PHARMACOKINETIC INTERACTION BETWEEN ITRACONAZOLE AND RIFAMPIN IN YUCATAN MINIATURE PIGS, Antimicrobial agents and chemotherapy, 40(9), 1996, pp. 2043-2046
Citation: D. Leveque et F. Jehl, DETERMINATION OF VINORELBINE IN BIOLOGICAL-FLUIDS BY HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 672(2), 1995, pp. 314-314
Authors:
LIMACHER JM
DUCLOS B
WIHLM J
LEVEQUE D
DUFOUR P
EICHLER F
KEILING R
BERGERAT JP
Citation: Jm. Limacher et al., PHASE-I STUDY OF HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID IN WEEKLY CONTINUOUS-INFUSION, European journal of cancer, 31A, 1995, pp. 945-945
Authors:
FAVRE JP
AUVRAY MH
SIGETY P
LEVEQUE D
BRIANCON C
Citation: Jp. Favre et al., IN-SITU MONITORING OF FIBER AND MATRIX DEFORMATION IN FIBER POLYMER COMPOSITES, Journal of Microscopy, 177, 1995, pp. 198-206
Authors:
LEVEQUE D
GALLION C
TARRAL E
MONTEIL H
JEHL F
Citation: D. Leveque et al., DETERMINATION OF FOSFOMYCIN IN BIOLOGICAL-FLUIDS BY CAPILLARY ELECTROPHORESIS, Journal of chromatography B. Biomedical applications, 655(2), 1994, pp. 320-324
Citation: J. Wihlm et al., PHARMACODYNAMICS OF 5-FLUOROURACIL COMBINED WITH CARBOPLATIN IN PATIENTS WITH HEAD AND NECK-CANCER, Anticancer research, 14(6A), 1994, pp. 2395-2396
Authors:
LEVEQUE D
QUOIX E
DUMONT P
MASSARD G
HENTZ JG
CHARLOUX A
JEHL F
Citation: D. Leveque et al., PULMONARY DISTRIBUTION OF VINORELBINE IN PATIENTS WITH NON-SMALL-CELLLUNG-CANCER, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 176-178
Authors:
LEVEQUE D
MERLEMELET M
BRESLER L
DIDELOT JP
AYMARD JP
WIHLM J
JEHL F
Citation: D. Leveque et al., BILIARY ELIMINATION AND PHARMACOKINETICS OF VINORELBINE IN MICROPIGS, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 487-490
Citation: D. Leveque et al., PHARMACOKINETIC PROFILE OF VINORELBINE, A NEW SEMISYNTHETIC VINCA ALKALOID, DETERMINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Xenobiotica, 23(11), 1993, pp. 1325-1333
Citation: J. Wihlm et al., THERAPEUTIC DRUG-MONITORING WITH DOSE ADJUSTMENT OF 5-FU ADMINISTRATED BY CONTINUOUS-INFUSION, Bulletin du cancer, 80(5), 1993, pp. 439-445